← Back to Search

Wearable Devices for Migraine Prediction

N/A
Waitlist Available
Led By Naraya Kissoon, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial seeks to use smart devices to track and predict headaches, allowing for earlier and more effective treatment.

Who is the study for?
This study is for adults with chronic migraines, who see at least a 50% improvement in headache frequency with their current treatment. Participants should have an average of 4-14 headache days per month and be able to use an iPhone and Apple Watch (provided) to track their health data.Check my eligibility
What is being tested?
The trial is testing if wearable devices like the Apple Watch can monitor heart rate and movement to predict when someone might get a migraine. The goal is to see if this tech can warn patients early so they can start treatments sooner.See study design
What are the potential side effects?
Since the intervention involves using eHealth applications on wearable devices, there are no direct medical side effects. However, participants may experience inconvenience or privacy concerns related to continuous health monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage accuracy of fit with AUC of the ROC (receiver operating characteristics) curve (%) for headache tracking.
Secondary outcome measures
Correlation coefficients of wearable sensor data to headache frequency and severity.
Percentage accuracy of fit with AUC of the ROC curve (%) for headache forecasting.
uMARS app quality mean score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Custom Phone eHealth ApplicationExperimental Treatment1 Intervention
Subjects diagnosed with migraine headaches and have had a positive response to prevention treatments for migraine, will wear an Apple Watch whenever possible (including during sleep) and complete application questionnaires on the eHealth application daily.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,767,063 Total Patients Enrolled
9 Trials studying Migraine
81,786 Patients Enrolled for Migraine
Naraya Kissoon, MDPrincipal InvestigatorMayo Clinic

Media Library

Custom Phone eHealth Application Clinical Trial Eligibility Overview. Trial Name: NCT05755945 — N/A
Migraine Research Study Groups: Custom Phone eHealth Application
Migraine Clinical Trial 2023: Custom Phone eHealth Application Highlights & Side Effects. Trial Name: NCT05755945 — N/A
Custom Phone eHealth Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755945 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open opportunities for participation in this clinical experiment?

"This investigation, which was initially posted on the 1st of March 2023 and last updated on the 23rd of February 2023, is no longer recruiting participants. Nonetheless, there are currently 179 other trials actively looking for volunteers."

Answered by AI
~1 spots leftby Jun 2024